BackPortage Biotech Overview

Portage Biotech Accounts Payable

Track Portage Biotech's accounts payable ($430K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$427000.00
11.41% YoYΔ $-55000.00 vs prior year quarter

Peer average

Loading

Portage Biotech Accounts Payable History

Loading

Portage Biotech vs. peers: Accounts Payable Comparison

Loading

Portage Biotech Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Portage Biotech (PRTG) FAQ

As of the most recent data (March 2025), PRTG shows a accounts payable of $430K. That compares with $480K in the prior-year period — down 11.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PRTG's accounts payable is now $430K (was $480K) — a 11.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Portage Biotech is outperforming or lagging.

Tracking PRTG's accounts payable over time shows whether Portage Biotech is scaling, shrinking, or reshaping that part of the business. The current reading is $430K That compares with $480K in the prior-year period — down 11.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Portage Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $430K) with ownership activity and broader fundamentals.

Portage Biotech's accounts payable is $430K; compare it with other Energy names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.